1.04
price down icon4.59%   -0.05
pre-market  プレマーケット:  1.02   -0.02   -1.92%
loading
前日終値:
$1.09
開ける:
$1.07
24時間の取引高:
111.76K
Relative Volume:
0.32
時価総額:
$19.61M
収益:
-
当期純損益:
$-33.08M
株価収益率:
-0.3537
EPS:
-2.94
ネットキャッシュフロー:
$-25.68M
1週間 パフォーマンス:
-8.77%
1か月 パフォーマンス:
-38.10%
6か月 パフォーマンス:
-30.67%
1年 パフォーマンス:
+34.85%
1日の値動き範囲:
Value
$1.01
$1.07
1週間の範囲:
Value
$0.92
$1.35
52週間の値動き範囲:
Value
$0.579
$2.55

Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile

Name
名前
Chemomab Therapeutics Ltd Adr
Name
セクター
Healthcare (1165)
Name
電話
972-77-331-0156
Name
住所
KIRYAT ATIDIM, BUILDING 7, TEL AVIV
Name
職員
20
Name
Twitter
Name
次回の収益日
2024-11-14
Name
最新のSEC提出書
Name
CMMB's Discussions on Twitter

CMMB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CMMB
Chemomab Therapeutics Ltd Adr
1.04 19.61M 0 -33.08M -25.68M -2.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-13 開始されました Maxim Group Buy
2024-05-06 アップグレード Oppenheimer Perform → Outperform
2023-12-19 再開されました ROTH MKM Buy

Chemomab Therapeutics Ltd Adr (CMMB) 最新ニュース

pulisher
Mar 27, 2025

The Aurora Cannabis Inc (NASDAQ: ACB) Stock Price: Is It Overvalued? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

How Stable And Growing Is Globavend Holdings Ltd (NASDAQ: GVH)? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Before Buying AYRO Inc (NASDAQ: AYRO) Stock, Read This First - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Is Advance Auto Parts Inc (NYSE: AAP) A Good Investment For New Investors Now? - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

Nu Holdings Ltd (NYSE: NU) Has Great Upside Potential - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

ZEEKR Intelligent Technology Holding Ltd. ADR (NYSE: ZK): Getting A Free Pass? - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

AT&T, Inc (NYSE: T) Jumps 1.59%: What Could Be On The Way Going Forward? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Adma Biologics Inc (NASDAQ: ADMA): Blank Check For Growth? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

A Bullish 2025 Outlook For Blink Charging Co (NASDAQ: BLNK) Shares - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

In 2025, Linkers Industries Ltd (NASDAQ: LNKS) Shares Will Likely Be Bullish - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Carrier Global Corp (NYSE: CARR): On Track To A Higher Share Price - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Before Buying Avantor Inc (NYSE: AVTR) Stock, Read This First - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

Ally Financial Inc (NYSE: ALLY): An Enticing Stock To Watch - stocksregister.com

Mar 27, 2025
pulisher
Mar 12, 2025

Does DLocal Limited (NASDAQ: DLO) Still Need To Convince Analysts? - stocksregister.com

Mar 12, 2025
pulisher
Mar 10, 2025

What Is Going On With Ondas Holdings Inc (NASDAQ: ONDS)? - stocksregister.com

Mar 10, 2025
pulisher
Mar 03, 2025

Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - stocksregister.com

Mar 03, 2025
pulisher
Feb 20, 2025

Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

How analysts predict Chemomab Therapeutics Ltd ADR (CMMB) will perform this quarter? - US Post News

Feb 19, 2025
pulisher
Jan 09, 2025

LogicMark Inc (LGMK) Recovers 0.71% From Low: Are We There Yet? - Stocks Register

Jan 09, 2025
pulisher
Nov 19, 2024

Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis - GlobeNewswire Inc.

Nov 19, 2024
pulisher
Nov 14, 2024

Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Investing.com

Nov 14, 2024
pulisher
Oct 15, 2024

Chemomab reports progress in PSC treatment trial - Investing.com

Oct 15, 2024
pulisher
Sep 20, 2024

Roth MKM Initiates Coverage of Chemomab Therapeutics LtdADR (CMMB) with Buy Recommendation - MSN

Sep 20, 2024
pulisher
Sep 16, 2024

The Chemomab Therapeutics Ltd ADR (CMMB) had a good session last reading, didn’t it? - US Post News

Sep 16, 2024
pulisher
Sep 09, 2024

Ratios Uncovered: Breaking Down Chemomab Therapeutics Ltd ADR (CMMB)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 09, 2024
pulisher
Feb 14, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 14, 2024
pulisher
Jan 13, 2023

Intercept (ICPT) Gains 12.4% in the Past Six Months: Here's Why - Zacks Investment Research

Jan 13, 2023
pulisher
Jun 24, 2021

Chemomab And AGC Biologics Partner To Manufacture CM-101 For Phase II/III - Contract Pharma

Jun 24, 2021
pulisher
Jun 17, 2021

What You Need To Know About Chemomab Therapeutics Ltd.'s (NASDAQ:CMMB) Investor Composition - Yahoo Finance

Jun 17, 2021
pulisher
Mar 23, 2021

CMMB News Today | Why did Chemomab Therapeutics stock go down today? - MarketBeat

Mar 23, 2021
pulisher
Dec 16, 2020

The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal - Yahoo Finance

Dec 16, 2020

Chemomab Therapeutics Ltd Adr (CMMB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):